See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Pioneer Group operates several funds specialising in pre-seed and seed funding for life sciences companies, with a preference to "get involved early." The firm provides vital life sciences investment primarily to companies it has worked with through its Accelerator Programme or those based at its science campuses across the UK and Ireland, allowing the team to know the people, technology and business well before investing. The Pioneer Ventures team — made up of scientists, entrepreneurs and investors — takes a hands-on, tailored approach, combining capital with direct advice, introductions to key people, lab and office space, and access to a wider network, all targeted at helping to build business success. Pioneer Group describes itself as "Europe's leading vertically integrated platform curating innovation-focused ecosystems that increase the chance of business success."
Notable quotes
“Our follow-on investment in NuVision reflects the quality of the company and its steady growth journey. We have been impressed by its uniquely innovative approach to treating ocular surface disease in a natural way. We are also confident that NuVision's effective solutions for regenerating and healing the eye surface have the potential to become real game-changers in ocular care.”
“Whilst it does not always follow that a well-funded company is going to be more successful, it is reasonable to assume that a poorly funded business will usually struggle, or develop more slowly. The development of a UK life sciences fund that can target £300m a year at spinouts from these top universities could have a significant impact.”
“This partnership is about creating joined-up pathways for founders – from early-stage programmes through to the specialist environments and networks they need as they grow.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Microneedle Solutions Ltd (MNS) | Seed | $4m | 2026-03-03 |
| NuVision Biotherapies Limited | Series B | $10m | 2026-02-05 |
| ImmuONE Limited | Seed | $1m | 2025-03-13 |
| NEOBE Therapeutics Limited | Seed | $4m | 2024-02-28 |
| Béa Fertility | Series A | $4m | 2023-11-22 |
| NuVision Biotherapies Limited | Seed | $1m | 2023-03-09 |
| BiVictriX Therapeutics Plc | Seed | — | — |
| Rinri Therapeutics Limited | Seed | — | — |
| EnteroBiotix | Seed | — | — |
| Novosound Limited | Seed | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Mercia Ventures | 3 |
| Midlands Engine Investment Fund (MEIF) | 3 |
| SFC Capital | 2 |
| 2048 Ventures | 1 |
| University of Nottingham | 1 |
| Hlx Life Sciences | 1 |
Fit check
Is Pioneer Group a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit